Xponance, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Xponance, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.06 - $1.67 $7,912 - $12,466	7,465 Added 10.81%	76,527 $88,000
Q4 2023 Jan 31, 2024	SELL	$1.26 - $1.79 $897 - $1,274	-712 Reduced 1.02%	69,062 $116,000
Q3 2023 Oct 23, 2023	BUY	$1.61 - $2.54 $1,983 - $3,129	1,232 Added 1.8%	69,774 $126,000
Q2 2023 Jul 13, 2023	BUY	$1.14 - $1.95 $27,659 - $47,312	24,263 Added 54.8%	68,542 $127,000
Q1 2023 Apr 17, 2023	SELL	$1.2 - $2.19 $7,305 - $13,332	-6,088 Reduced 12.09%	44,279 $58,000
Q4 2022 Jan 23, 2023	BUY	$1.63 - $3.52 $26,836 - $57,953	16,464 Added 48.56%	50,367 $0
Q3 2022 Oct 24, 2022	BUY	$0.73 - $3.74 $337 - $1,731	463 Added 1.38%	33,903 $106,000
Q2 2022 Aug 02, 2022	BUY	$2.2 - $4.2 $73,568 - $140,448	33,440 New	33,440 $80,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.